Viewing Study NCT01593761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2025-12-27 @ 9:12 PM
Study NCT ID: NCT01593761
Status: COMPLETED
Last Update Posted: 2022-09-10
First Post: 2012-05-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus
Sponsor: CrystalGenomics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cABSSSI View
None MRSA View